EIDOS THERAPEUTICS INC's ticker is EIDX and the CUSIP is 28249H104. A total of 79 filers reported holding EIDOS THERAPEUTICS INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $23,501,000 | +237.3% | 178,608 | +29.5% | 0.06% | +181.8% |
| Q3 2020 | $6,968,000 | -4.2% | 137,900 | -9.6% | 0.02% | -12.0% |
| Q2 2020 | $7,273,000 | -48.3% | 152,564 | -46.9% | 0.02% | -59.7% |
| Q1 2020 | $14,081,000 | -31.6% | 287,426 | -19.9% | 0.06% | -10.1% |
| Q4 2019 | $20,581,000 | +9.4% | 358,611 | -31.4% | 0.07% | +7.8% |
| Q3 2019 | $18,813,000 | +5.4% | 523,015 | -9.0% | 0.06% | +10.3% |
| Q2 2019 | $17,854,000 | +164.2% | 574,466 | +99.3% | 0.06% | +152.2% |
| Q1 2019 | $6,759,000 | – | 288,222 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|